跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,059 条关于
“IKB Deutsche Industriebank AG”
全部
4,059
临床试验
2,308
药物
731
机构
318
资讯
702
去年
Formycon Launches €50 Million Corporate Bond to Accelerate Biosimilar Portfolio Development
6个月前
AtaiBeckley Explores $2 Billion Deal for Psychedelic Depression Drug as Deutsche Bank Sees Major Market Potential
去年
Fabhalta Demonstrates Sustained Efficacy in Phase III C3 Glomerulopathy Trial
3个月前
Jefferies Analysts Issue Mixed Ratings on Pharma Giants Novartis and Sanofi
去年
Formycon's Aflibercept Biosimilar, AHZANTIVE®/Baiama®, Receives Positive CHMP Opinion for EU Approval
2年前
4SC AG Receives MHRA Waiver for Resminostat in Pediatric CTCL
3年前
4SC's Resminostat Advances Towards European Market Approval for CTCL Maintenance Therapy
去年
Tiprelestat Shows Promise in COVID-19 Patients: tiakis Biotech Announces Phase Ib/II Trial Results
4年前
RESMAIN Study: Resminostat Shows Promise in Cutaneous T-Cell Lymphoma Maintenance
6年前
RESMAIN Trial of Resminostat for CTCL Maintenance Continues After Positive Safety Review
第 1 页，共 71 页
上一页
下一页
